[go: up one dir, main page]

FI67214C - Foerfarande foer framstaellning av nya terapeutiskt vaerdefulla taurinderivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt vaerdefulla taurinderivat Download PDF

Info

Publication number
FI67214C
FI67214C FI821650A FI821650A FI67214C FI 67214 C FI67214 C FI 67214C FI 821650 A FI821650 A FI 821650A FI 821650 A FI821650 A FI 821650A FI 67214 C FI67214 C FI 67214C
Authority
FI
Finland
Prior art keywords
therapeutic
compounds
effect
taurine
added
Prior art date
Application number
FI821650A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI821650A0 (fi
FI67214B (fi
FI821650L (fi
Inventor
Lars Henrik Andersen
Leif Albin Ingemar Hilden
Original Assignee
Medica Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medica Pharma Co Ltd filed Critical Medica Pharma Co Ltd
Publication of FI821650A0 publication Critical patent/FI821650A0/fi
Publication of FI821650L publication Critical patent/FI821650L/fi
Publication of FI67214B publication Critical patent/FI67214B/sv
Application granted granted Critical
Publication of FI67214C publication Critical patent/FI67214C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
FI821650A 1980-06-06 1982-05-11 Foerfarande foer framstaellning av nya terapeutiskt vaerdefulla taurinderivat FI67214C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8004261A SE434638B (sv) 1980-06-06 1980-06-06 Nya terapeutiska verdefulla taurinderivat och deras framstellning
SE8004261 1980-06-06
PCT/FI1981/000037 WO1981003492A1 (fr) 1980-06-06 1981-05-22 Composes chimiques, leur production et leur utilisation dans des medicaments
FI8100037 1981-05-22

Publications (4)

Publication Number Publication Date
FI821650A0 FI821650A0 (fi) 1982-05-11
FI821650L FI821650L (fi) 1982-05-11
FI67214B FI67214B (fi) 1984-10-31
FI67214C true FI67214C (fi) 1985-02-11

Family

ID=20341162

Family Applications (1)

Application Number Title Priority Date Filing Date
FI821650A FI67214C (fi) 1980-06-06 1982-05-11 Foerfarande foer framstaellning av nya terapeutiskt vaerdefulla taurinderivat

Country Status (26)

Country Link
US (1) US4556673A (fr)
JP (1) JPS57500877A (fr)
AT (1) AT376206B (fr)
BE (1) BE889100A (fr)
CA (1) CA1165322A (fr)
CH (1) CH647505A5 (fr)
CS (2) CS235088B2 (fr)
DD (1) DD159427A5 (fr)
DE (1) DE3152071C2 (fr)
DK (1) DK155521B (fr)
ES (1) ES8203342A1 (fr)
FI (1) FI67214C (fr)
FR (1) FR2486077B1 (fr)
GB (1) GB2093457B (fr)
HU (1) HU184871B (fr)
IE (1) IE51264B1 (fr)
IL (1) IL62824A (fr)
IT (1) IT8122151A0 (fr)
NL (1) NL8120217A (fr)
NO (1) NO155840C (fr)
PL (2) PL128574B1 (fr)
PT (1) PT73061B (fr)
SE (1) SE434638B (fr)
SU (1) SU1097198A3 (fr)
WO (1) WO1981003492A1 (fr)
ZA (1) ZA813387B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458606B (sv) * 1987-04-10 1989-04-17 Huhtamaeki Oy 2-ftalimidoetansulfon-n-arylamider och foerfarande foer framstaellning av dessa
US5801195A (en) 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
AR016384A1 (es) 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
AU2006200033B8 (en) * 1998-10-30 2008-09-11 Celgene Corporation Substituted phenethylsulfones and methods of reducing TNF-alpha levels
US6020358A (en) * 1998-10-30 2000-02-01 Celgene Corporation Substituted phenethylsulfones and method of reducing TNFα levels
US6667316B1 (en) 1999-11-12 2003-12-23 Celgene Corporation Pharmaceutically active isoindoline derivatives
US6699899B1 (en) * 1999-12-21 2004-03-02 Celgene Corporation Substituted acylhydroxamic acids and method of reducing TNFα levels
US6326388B1 (en) 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
US8030343B2 (en) * 2000-06-08 2011-10-04 Celgene Corporation Pharmaceutically active isoindoline derivatives
US7491634B2 (en) * 2006-04-28 2009-02-17 Asm International N.V. Methods for forming roughened surfaces and applications thereof
EP1401805A1 (fr) * 2001-06-26 2004-03-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Derives de valproyltaurinamide utilises comme anticonvulsants et agents cns actifs
US7244759B2 (en) * 2004-07-28 2007-07-17 Celgene Corporation Isoindoline compounds and methods of making and using the same
CN114539106B (zh) * 2022-03-15 2023-05-02 梯尔希（南京）药物研发有限公司 一种稳定同位素标记的牛磺酰胺盐酸盐的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2184279A (en) * 1937-11-27 1939-12-26 Squibb & Sons Inc Amino-aliphatic sulphonamides and process for preparing them
AT219039B (de) * 1959-05-27 1962-01-10 Geigy Ag J R Verfahren zur Herstellung von neuen Isoindolinderivaten
GB1254414A (en) * 1969-05-08 1971-11-24 Shun-Ichi Naito Novel aminoethanesulfonylamino derivatives and their production
US4093723A (en) * 1976-05-19 1978-06-06 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl) cephalosporins
ZA76757B (en) * 1975-03-18 1977-01-26 Smithkline Corp New cephalosporin compounds
US4048311A (en) * 1976-01-08 1977-09-13 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl)cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
WO1981003492A1 (fr) 1981-12-10
ATA907681A (de) 1984-03-15
PT73061B (en) 1982-07-01
BE889100A (fr) 1981-12-04
DK30082A (da) 1982-01-25
DK155521B (da) 1989-04-17
AT376206B (de) 1984-10-25
ES502761A0 (es) 1982-04-01
US4556673A (en) 1985-12-03
PL128574B1 (en) 1984-02-29
SU1097198A3 (ru) 1984-06-07
FI821650A0 (fi) 1982-05-11
FI67214B (fi) 1984-10-31
IL62824A0 (en) 1981-07-31
CH647505A5 (de) 1985-01-31
DE3152071T1 (de) 1983-10-20
CA1165322A (fr) 1984-04-10
CS235091B2 (en) 1985-04-16
SE434638B (sv) 1984-08-06
GB2093457A (en) 1982-09-02
FR2486077A1 (fr) 1982-01-08
NO155840B (no) 1987-03-02
CS235088B2 (en) 1985-04-16
JPS57500877A (fr) 1982-05-20
PL231531A1 (fr) 1982-08-30
FI821650L (fi) 1982-05-11
FR2486077B1 (fr) 1988-08-12
IE51264B1 (en) 1986-11-26
PL128321B1 (en) 1984-01-31
NO820213L (no) 1982-01-25
IE811037L (en) 1981-12-06
ES8203342A1 (es) 1982-04-01
NO155840C (no) 1987-06-10
PL235510A1 (fr) 1982-11-22
DD159427A5 (de) 1983-03-09
HU184871B (en) 1984-10-29
NL8120217A (fr) 1982-08-02
GB2093457B (en) 1984-03-21
ZA813387B (en) 1982-06-30
PT73061A (en) 1981-06-01
SE8004261L (sv) 1981-12-07
IL62824A (en) 1984-07-31
IT8122151A0 (it) 1981-06-05
DE3152071C2 (de) 1989-06-15

Similar Documents

Publication Publication Date Title
FI67214C (fi) Foerfarande foer framstaellning av nya terapeutiskt vaerdefulla taurinderivat
DE69819703T2 (de) Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
MXPA04010921A (es) Metodos y composiciones para el tratamietno de trastornos del sistema nervioso central y periferico y compuestos novedosos utiles para los mismos.
PT99202A (pt) Processo para a preparacao de composicoes antimicrobianas contendo derivados de ciclo-hexan-1-ilamina substituidos e para a preparacao de novos derivados de ciclo-hexan-1-ilamina substituidos com propriedades antimicrobianas
DE69832268T2 (de) Peptidyl2-amino-1hydroxyalkansulfonsäuren als zysteinprotease-inhibitoren
DE69927007T2 (de) Spisulosin-verbindungen mit antitumor-aktivität
DE60018194T2 (de) Hydroxamsäurederivate, verfahren zu ihrer herstellung und medikamente die diese als aktiven wirkstoff enthalten
Werbel et al. Basically substituted ellipticine analogs as potential antitumor agents
CA3033497A1 (fr) Peptides modifies destines a etre utilises dans le traitement de troubles neurodegeneratifs
US4151298A (en) Anthelmintic compositions
Angelova et al. Anticonvulsant activity of newly synthesized 2H-chromene based hydrazones in ICR mice
US8987253B2 (en) Compound having activity of blocking NMDA receptor channel, and pharmaceutical agent using the same
Wang et al. Synthesis and biological evaluation of peptidomimetics containing the tryptamine moiety as a potential antitumor agent
SE435927B (sv) Trans-4-(2-klorofenoxi)-1-etyl-pyrrolidinol med terapeutisk verkan
KR0182276B1 (ko) 나프톡사진의 약학적 용도
Spano et al. 1-Adamantanecarboxylic acid amide of 4-aminoantipyrine
ITMI991742A1 (it) Bisplatino complessi attivi per via orale
EP2332529A1 (fr) Diamines aromatiques substituées en tant que ligands des transporteurs de glutamate vésiculaires 1 et 2 (vGLUT1 et vGLUT2)
SU763345A1 (ru) Замещенные амиды 2-/2 -(5"-нитрофурил2")-винил-и4-(5"нитрофурил-2")-1,3бутадиенил/-хинолин-4-карбоновых кислот или их водорастворимые соли,обладающие антибластическим действием
US3423412A (en) Benzopyrroloquinazolinones
TW390879B (en) Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids having antibacterial activities, their preparation and pharmaceutical composition containing the same
RU2477144C2 (ru) Лекарственное средство с антиаритмическим и антифибрилляторным действием
Narayanan et al. Synthesis and antiarrhythmic activity of some N-(adamantylaminoalkyl) benzamides
JPH0229669B2 (fr)
EP3917510A1 (fr) Antagonistes du melastatin potentiel de récepteur transitoire 8 (trpm8) et méthodes associées

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: LAEKEMEDELSFABRIKEN-MEDICA AB